(1)
Fang, Y. Advances in the Clinical Application of Novel PCSK9 Inhibitors for High-Risk Atherosclerotic Cardiovascular Disease. IJBLS 2026, 16 (1), 15-25. https://doi.org/10.54097/wp0rhk16.